BirchBioMed Inc. filed an amended Form D with the Securities and Exchange Commission on 2025-07-11.
BirchBioMed Inc. filed an amended Form D notice of an exempt securities offering with the SEC on July 11, 2025. The filing reports $2.48M sold. Its industry group is Biotechnology. It names Mark Miller (Executive Officer, Director, Promoter), John Verbeck (Executive Officer), Susan Elliott (Executive Officer, Director, Promoter) (SEC Form D/A, July 11, 2025).
Is this your company?
Sell to companies like BirchBioMed Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
New Form D on file · 2025-07-11 · the record
Pitching, partnering or investing alongside them? See who really runs and owns BirchBioMed Inc.
Free to see. No signup.
More on the people and the money behind BirchBioMed Inc., from the filings we hold.
Biotechnology raises filed within 90 days of this one, largest first.
Get an email when BirchBioMed Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
We'll show it in your MentionFox inbox when BirchBioMed Inc. raises, hires or launches. No email unless you switch it on.
Watch BirchBioMed Inc. →Get the full cited report on BirchBioMed Inc.
What the filing shows about BirchBioMed Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on BirchBioMed Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
The filing gives BirchBioMed Inc.'s address as 130 Kingscross Drive, King City, A6 L7B 1E6.
Saved here on this device in the meantime, so nothing is lost either way.
Amended on 2025-10-01: the offering size changed from $3,000,000 to $5,000,000; the amount sold changed from $175,000 to $2,480,000; the number of investors changed from 5 to 18. Figures on this page are from the amendment. Amended filing · Original filing
This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.
BirchBioMed Inc. is a registered filer with the SEC (CIK 1670747) and has filed since 2025-07-11. 2 filings are on record, the latest on 2025-10-01.
A filing shows the company exists and what it reports about itself. It is not an audit or a rating.
BirchBioMed Inc.'s Form D of 2025-07-11 names Mark Miller, John Verbeck, Susan Elliott and 5 more as its officers, directors or promoters.
Its new offerings report $175K sold across 1 offering, as its own filings state.
A hollow marker is an amendment (Form D/A); a solid one is an original Form D. The larger marker is the filing this page is about.
Trailing twelve months. 769 filings in Biotechnology, totalled by week.
Mark Miller is named as Executive Officer and Director and Promoter on the Form D that BirchBioMed Inc. filed with the SEC on 11 July 2025, one of 8 people that filing names.
John Verbeck is named as Executive Officer on the Form D that BirchBioMed Inc. filed with the SEC on 11 July 2025, one of 8 people that filing names.
Susan Elliott is named as Executive Officer and Director and Promoter on the Form D that BirchBioMed Inc. filed with the SEC on 11 July 2025, one of 8 people that filing names.
Carlos Camozzi is named as Executive Officer on the Form D that BirchBioMed Inc. filed with the SEC on 11 July 2025, one of 8 people that filing names.
Teresa Bair is named as Director on the Form D that BirchBioMed Inc. filed with the SEC on 11 July 2025, one of 8 people that filing names.
Charles Ellis is named as Director on the Form D that BirchBioMed Inc. filed with the SEC on 11 July 2025, one of 8 people that filing names.
Joseph Sardano is named as Director on the Form D that BirchBioMed Inc. filed with the SEC on 11 July 2025, one of 8 people that filing names.
Herve Girsault is named as Executive Officer on the Form D that BirchBioMed Inc. filed with the SEC on 11 July 2025, one of 8 people that filing names.
8 people named on the filing — 5 holding an executive role and 3 as directors only.
Named as of the 2025-07-11 filing. Titles and locations are exactly as the filing states — not independently confirmed elsewhere.
No investor is drawn from a Form D — the form states how many invested and never who.
What the filing shows about BirchBioMed Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on BirchBioMed Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on BirchBioMed Inc. covers
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist BirchBioMed Inc.You get an alert in MentionFox the next time this company shows up.
If you're behind BirchBioMed Inc.: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.
Sourced from the filing index on sec.gov.
Each opens in a new tab, filled in for BirchBioMed Inc.. With no account yet, you sign up free and land on the result.
Share your raise. This card is drawn from the company's own Form D filing, and sharing needs no account.
https://mentionfox.com/funding/birchbiomed-inc-form-d-25000001